Nutrients associated with metabolic dysfunction-associated steatotic liver disease [0.03%]
与代谢紊乱相关性脂肪肝病相关的营养因素
Seogsong Jeong
Seogsong Jeong
In situ or ex situ split: Does it all come down to static cold storage? [0.03%]
原位还是异体裂解，是否都归结于静态冷储存？
Xavier Muller,Guillaume Rossignol,Natacha Boulanger et al.
Xavier Muller et al.
Retraction notice to "Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy" [J Hepatol 62 (3) (2015) 647-656] [0.03%]
撤稿：醛脱氢酶-2通过调节自噬在改善慢性酒精性肝脂肪变性和炎症中发挥了积极作用[J Hepatol 62 (3) (2015) 647-656] 撤稿通知
Rui Guo,Xihui Xu,Sara A Babcock et al.
Rui Guo et al.
Retraction of Publication
Journal of hepatology. 2023 Oct;79(4):1072. DOI:10.1016/j.jhep.2023.08.011 2023
Reply to: "Excellent long-term outcomes after sequential hypothermic and normothermic machine perfusion challenges the importance of functional donor warm ischemia time in DCD liver transplantation": Further comments on the changing role of donor warm ischemia time in DCD liver selection in the era of machine perfusion [0.03%]
关于“序贯低温和常温机械灌注后的DCD肝移植长期疗效优秀质疑供肝温热缺血时间的重要性”的回复：机器灌注时代下DCD肝脏选择中供肝温热缺血时间角色变化的进一步评论
Riccardo De Carlis,Andrea Lauterio,Davide Bernasconi et al.
Riccardo De Carlis et al.
Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of hepatitis C virus with antivirals [0.03%]
基于机器学习的干扰素根除丙型肝炎病毒后个体患者肝细胞癌发病预测模型
Tatsuya Minami,Masaya Sato,Hidenori Toyoda et al.
Tatsuya Minami et al.
Background and aims: Accurate risk stratification for hepatocellular carcinoma (HCC) after achieving a sustained viral response (SVR) is necessary for optimal surveillance. We aimed to develop and validate a machine learn...
Reply to: "Early neurological worsening in Wilson disease: The need for an evidence-based definition" [0.03%]
威尔逊病早期神经恶化：需要基于证据的定义回复文章
Isabelle Mohr,Aurélia Poujois,Aftab Ala et al.
Isabelle Mohr et al.
Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD [0.03%]
不同命名法（NAFLD、MAFLD、MASLD 和 MetALD）下的脂肪肝疾病的临床和组织学特征
Lin Chen,Xuemei Tao,Minghui Zeng et al.
Lin Chen et al.
Immunosuppressive CD10+ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells [0.03%]
CD10+ALPL+免疫抑制性中性粒细胞通过介导T细胞不可逆耗竭促进肝癌患者抗PD-1治疗抵抗
Yan Meng,Fei Ye,Pingping Nie et al.
Yan Meng et al.
Background & aims: Remodeling the tumor microenvironment is a critical strategy for treating advanced hepatocellular carcinoma (HCC). Yet, how distinct cell populations in the microenvironment mediate tumor resistance to ...
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation [0.03%]
AFP-L3和DCP可强预测肝移植后早期肝癌复发
Joshua S Norman,P Jonathan Li,Prashant Kotwani et al.
Joshua S Norman et al.
Background & aims: Alpha-fetoprotein (AFP) predicts hepatocellular carcinoma (HCC) recurrence after liver transplant (LT) but remains an imperfect biomarker. The role of DCP (des-gamma-carboxyprothrombin) and AFP-L3 (AFP ...
Is the change from NAFLD to MASLD driven by political correctness? [0.03%]
从NAFLD到MASLD的改变是由政治正确性驱动的吗？
Madhusudana Girija Sanal
Madhusudana Girija Sanal